Heikki Minn - UTU Research Portal

Heikki Minn

- ,
Department of Clinical Medicine (Faculty of Medicine)
- Docent,
Faculty of Medicine (University of Turku)

heikki.minn@utu.fi

: https://orcid.org/0000-0002-5878-4333

3 of 8

Repeatability of hypoxia dose painting by numbers based on EF5-PET in head and neck cancer (2021)
- Acta Oncologica
Wright Pauliina, Arnesen Marius Røthe, Lønne Per Ivar, Suilamo Sami, Silvoniemi Antti, Dale Einar, Minn Heikki, Malinen Eirik
Somatostatin Receptors and Chemokine Receptor CXCR4 in Lymphomas: A Histopathological Review of Six Lymphoma Subtypes (2021)
- Frontiers in Oncology
Juntikka Tiina, Vaittinen Samuli, Vahlberg Tero, Jyrkkiö Sirkku, Minn Heikki
Statistical Evaluation of Different Mathematical Models for Diffusion Weighted Imaging of Prostate Cancer Xenografts in Mice (2021)
- Frontiers in Oncology
Merisaari Harri, Laakso Hanne, Liljenbäck Heidi, Virtanen Helena, Aronen Hannu J., Minn Heikki, Poutanen Matti, Roivainen Anne, Liimatainen Timo, Jambor Ivan
[18F]Fluciclovine PET/CT: joint EANM and SNMMI procedure guideline for prostate cancer imaging-version 1.0. (2020)
- European Journal of Nuclear Medicine and Molecular Imaging
Nanni C, Zanoni L, Bach-Gansmo T, Minn H, Willoch F, Bogsrud TV, Edward EP, Savir-Baruch B, Teoh E, Ingram F, Fanti S, Schuster DM
Aivokasvainten hoito ja moniammatillinen neuro-onkologiaryhmä (2020)
- Duodecim
Minn Heikki, Lahtela Sirpa-Liisa, Palovaara Sanna, Suilamo Sami, Gardberg Maria, Karhu Jari, Posti Jussi P
An easily adaptable validated risk score predicts cancer-specific survival in stage II colon cancer (2020)
- Acta Oncologica
Eetu Heervä, Vesa Väliaho, Tapio Salminen, Lasse Nieminen, Anu Carpelan, Samu Kurki, Jari Sundström, Heikki Huhtinen, Arto Rantala, Olli Carpén, Heikki Minn, Pia Österlund, Annika Ålgars, Raija Ristamäki
Comparison of Cost and Time Effectiveness between CT- and MRI-based Radiotherapy Workflow for Prostate Cancer (2020)
- Communications in Computer and Information Science
Well-Being in the Information Society. Fruits of Respect: 8th International Conference, WIS 2020, Turku, Finland, August 26–27, 2020, Proceedings Olli Sjöblom, Sonja Turnbull-Smith, Heikki Minn, Jani Keyriläinen
Eturauhassyövän entsyymikuvantaminen PET-menetelmällä (2020)
- Duodecim
Seppänen M, Boström PJ, Minn H, Kemppainen J
European practice patterns and barriers to smoking cessation after a cancer diagnosis in the setting of curative versus palliative cancer treatment (2020)
- European Journal of Cancer
Jeroen W.G. Derksen, Graham W. Warren, Karin Jordan, Stefan Rauh, Ruth Vera Garcıa, Deirdre O’Mahony, Samreen Ahmed, Peter Vuylsteke, Sinisa Radulovic, Nikolaos Tsoukalas, Piotr J. Wysocki, Markus Borner, Alvydas Cesas, Anneli Elme, Heikki Minn, Gustav J. Ullenhag, Jeanine M.L. Roodhart, Miriam Koopman, Anne M. May
How public health services pay for radiotherapy in Europe: an ESTRO–HERO analysis of reimbursement (2020)
- Lancet Oncology
Lievens Y., Defourny N., Corral J., Gasparotto C., Grau C., Borras J.M., Kozma E., Sedlmayer F., Slobina E., Daisne J.F., Hadjieva T., Petera J., Kristensen B.H., Valgma M., Minn H., Chauvet B., Troost E.G., Lopez Medina A., Kouloulias V., Takácsi-Nagy Z., Coffey M., Russi E., Jarusevicius L., Untereiner M., Smichkoska S., Karadjinovic V., Van Loon J., Malicki J., Trigo M.L., Coza O., Roques T., Mohammed N., Rolles M., Rolles M.
Once-a-week or every-other-day urethra-sparing prostate cancer stereotactic body radiotherapy, a randomized phase II trial: 18 months follow-up results (2020)
- Cancer Medicine
Zilli T, Jorcano S, Bral S, Rubio C, Bruynzeel AME, Oliveira A, Abacioglu U, Minn H, Symon Z, Miralbell R
Ongoing and future clinical trials in particle therapy in the Nordic countries (2020)
- Acta Oncologica
Petra Witt Nyström, Åse Bratlan, Heikki Minn, Cai Grau
PET-tutkimus syövän hoitovasteen seurannassa ja uusiutumisen toteamisessa (2020)
- Duodecim
Schildt Jukka, Sipilä Kalle, Minn Heikki
Prediction of prostate cancer aggressiveness using 18 F-Fluciclovine (FACBC) PET and multisequence multiparametric MRI (2020)
- Scientific Reports
Movahedi P, Merisaari H, Perez IM, Taimen P, Kemppainen J, Kuisma A, Eskola O, Teuho J, Saunavaara J, Pesola M, Kähkönen E, Ettala O, Liimatainen T, Pahikkala T, Boström P, Aronen H, Minn H, Jambor I
The FLUKA Monte Carlo code coupled with an OER model for biologically weighted dose calculations in proton therapy of hypoxic tumors (2020)
- Physica Medica
Tordis Johnsen Dahle, Espen Rusten, Camilla Hanquist Stokkevåg, Antti Silvoniemi, Andrea Mairan, Lars Fredrik Fjæra, Eivind Rørvik, Helge Henjum, Pauliina Wright, Camilla Grindeland Boer, Sarita Forsback, Heikki Minn, Eirik Malinen, Kristian Smeland Ytre-Hauge
Urethra-Sparing Stereotactic Body Radiation Therapy for Prostate Cancer: Quality Assurance of a Randomized Phase 2 Trial (2020)
- International Journal of Radiation Oncology - Biology - Physics
Maud Jaccard, Thomas Zilli, Angèle Dubouloz, Luís Escude, Sandra Jorcano, Nadine Linthout, Samuel Bral, Wilko Verbakel, Anna Bruynzeel, Mikko Björkqvist, Heikki Minn, Lev Tsvang, Zvi Symon, Joana Lencart, Angelo Oliveira, Zeynep Ozen, Ufuk Abacioglu, Juan María Pérez-Moreno,Carmen Rubio, Michel Rouzaud, Raymond Miralbell
Uusia työkaluja paikallisesti edenneen ja etäpesäkkeisen eturauhassyövän lääkehoitoon (2020)
- Duodecim
Virtanen V, Rautiola H, Poutanen M, Boström PJ, Minn H, Sundvall M.
Validation of automated magnetic resonance image segmentation for radiation therapy planning in prostate cancer (2020)
- Physics and Imaging in Radiation Oncology
Anna Kuisma, Iiro Ranta, Jani Keyriläinen, Sami Suilamo, Pauliina Wright, Marko Pesola, Lizette Warner, Eliisa Löyttyniemi, Heikki Minn
Assessment of dosimetric and positioning accuracy of a magnetic resonance imaging-only solution for external beam radiotherapy of pelvic anatomy (2019)
- Physics and Imaging in Radiation Oncology
Kemppainen R., Suilamo S., Ranta I., Pesola M., Halkola A., Eufemio A., Minn H., Keyriläinen J.
Correlation between 18F-1-amino-3-fluorocyclobutane-1-carboxylic acid (18F-fluciclovine) uptake and expression of alanine-serine-cysteine-transporter 2 (ASCT2) and L-type amino acid transporter 1 (LAT1) in primary prostate cancer (2019)
- EJNMMI Research
Irena Saarinen, Ivan Jambor, Mai Kim, Anna Kuisma, Jukka Kemppainen, Harri Merisaari, Olli Eskola, Anna-Riina Koskenniemi, Ileana Montoya Perez, Peter Boström, Pekka Taimen, Heikki Minn